Insulin vaccine for type 1 diabetes undergoes second trial

Insulin vaccine for type 1 diabetes undergoes second trial

This post was originally published on this site
A vaccination against type 1 diabetes will soon also be available to young children: the Pre-POINTearly vaccination study will involve children between the ages of six months and two years from across Germany who have a first-degree relative with type 1 diabetes. In the preceding Pre-POINT study a positive immune response was triggered in children aged between two and seven years with the aid of powdered insulin.

Start the conversation, or Read more at PhysOrg Weblog.